MANCINI, NICASIO
 Distribuzione geografica
Continente #
EU - Europa 5.249
AS - Asia 4.043
NA - Nord America 3.156
SA - Sud America 1.089
AF - Africa 104
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.654
Nazione #
US - Stati Uniti d'America 2.985
RU - Federazione Russa 2.792
SG - Singapore 1.390
CN - Cina 1.272
IT - Italia 904
BR - Brasile 888
SE - Svezia 613
HK - Hong Kong 538
VN - Vietnam 407
FR - Francia 222
DE - Germania 202
GB - Regno Unito 117
IN - India 108
FI - Finlandia 92
CA - Canada 91
AR - Argentina 77
NL - Olanda 69
MX - Messico 52
PL - Polonia 49
AT - Austria 47
BD - Bangladesh 47
IE - Irlanda 42
ZA - Sudafrica 42
EC - Ecuador 41
JP - Giappone 39
TR - Turchia 35
IQ - Iraq 34
ES - Italia 31
ID - Indonesia 30
CO - Colombia 22
SA - Arabia Saudita 21
UZ - Uzbekistan 20
PK - Pakistan 15
PY - Paraguay 14
CL - Cile 13
LT - Lituania 13
PH - Filippine 13
MA - Marocco 12
PE - Perù 12
VE - Venezuela 11
TN - Tunisia 10
IR - Iran 9
JO - Giordania 9
UA - Ucraina 9
EG - Egitto 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
DZ - Algeria 7
AZ - Azerbaigian 6
BE - Belgio 6
KE - Kenya 6
NI - Nicaragua 6
UY - Uruguay 6
HU - Ungheria 5
JM - Giamaica 5
KZ - Kazakistan 5
MY - Malesia 5
RS - Serbia 5
CR - Costa Rica 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GA - Gabon 4
IL - Israele 4
AL - Albania 3
BH - Bahrain 3
CM - Camerun 3
GY - Guiana 3
HR - Croazia 3
KR - Corea 3
MU - Mauritius 3
PA - Panama 3
PS - Palestinian Territory 3
A1 - Anonimo 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EU - Europa 2
GD - Grenada 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
Totale 13.643
Città #
Singapore 626
Moscow 606
Dallas 548
Hong Kong 535
Ashburn 505
Shanghai 291
San Jose 286
Milan 282
Hefei 187
Beijing 186
Ho Chi Minh City 162
Lauterbourg 162
New York 153
Princeton 153
Lawrence 150
Los Angeles 97
São Paulo 90
Hanoi 82
Rome 60
Munich 59
Helsinki 58
Warsaw 45
Chennai 43
Nuremberg 42
Orem 40
Santa Clara 37
Stockholm 37
Turin 36
Dublin 34
Tokyo 34
Montreal 33
Florence 32
Johannesburg 32
Boardman 31
Brescia 30
Denver 30
London 30
Poplar 27
Bologna 25
Atlanta 24
Belo Horizonte 24
Turku 24
Toronto 23
Cesano Boscone 22
Guangzhou 21
Houston 21
Brooklyn 20
Frankfurt am Main 20
Rio de Janeiro 20
Seattle 20
Vienna 20
Haiphong 19
Amsterdam 18
Boston 18
Falkenstein 18
Mexico City 18
Shenzhen 18
The Dalles 18
Chicago 17
Tashkent 17
Campinas 15
Phoenix 15
Council Bluffs 14
Porto Alegre 14
Brasília 13
Curitiba 13
Pune 13
Ankara 12
Catania 12
Columbus 12
Guayaquil 12
Hangzhou 12
Manchester 12
Mumbai 12
Salvador 12
Washington 12
Baghdad 11
Biên Hòa 11
Da Nang 11
San Francisco 11
Sorocaba 11
Tianjin 11
Genoa 10
Guarulhos 10
Quito 10
Lappeenranta 9
Paris 9
Amman 8
Barnet 8
Changsha 8
Dhaka 8
Jakarta 8
Jeddah 8
Jiaxing 8
Manaus 8
Querétaro 8
Riyadh 8
Bari 7
Calgary 7
Can Tho 7
Totale 6.736
Nome #
A modified Frosch approach for posterior tibial plateau fractures: Technical note and case series 599
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 159
Beauveria bassiana Keratitis: A Case Series and Review of Literature 156
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 151
Biobanking for COVID-19 research 144
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 130
Answer to Photo Quiz: Scolecobasidium sp 130
The interferon landscape along the respiratory tract impacts the severity of COVID-19 128
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 127
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 127
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 125
A Biologically-validated HCV E1E2 Heterodimer Structural Model 125
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 124
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 121
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 120
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 119
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 119
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 118
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 117
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 116
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota 115
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 115
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 114
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 113
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 112
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 110
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 106
A new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue 105
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 103
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 101
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 101
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 101
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 101
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules 97
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 97
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 97
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 97
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 96
A closer look at prion strains: Characterization and important implications 96
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 96
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 96
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 95
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 95
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 95
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 93
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy 92
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 91
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 91
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 91
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 91
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 90
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 90
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients 87
Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice 86
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 86
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 86
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 85
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 85
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 83
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 82
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 82
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 82
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 81
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 81
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 80
Analysis of the Enteric Microbiome: First Tentative Steps Towards a Comprehensive Work-up of Prostate Cancer? 80
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 79
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 79
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 79
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 79
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 78
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 78
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 78
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 77
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 77
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 76
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 76
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 75
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 75
Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay 74
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 73
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 73
Coronaviridae and SARS-associated coronavirus strain HSR1 72
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals 72
HCV E2 core structures and mAbs: something is still missing 71
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 70
Role and potential therapeutic use of antibodies against herpetic infections 69
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 68
Viral Respiratory Pathogens and Lung Injury 68
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 67
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 66
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 65
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 64
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 63
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 63
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 62
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard” 62
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 62
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 61
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 61
Totale 9.816
Categoria #
all - tutte 78.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 7 1 0
2021/2022142 3 7 20 29 13 7 13 9 4 10 6 21
2022/20231.082 350 259 98 15 22 127 62 65 49 7 14 14
2023/2024756 27 40 101 92 53 149 34 70 9 23 42 116
2024/20252.998 314 65 68 111 124 240 434 367 494 301 237 243
2025/20268.813 692 716 760 1.319 731 327 754 674 2.493 347 0 0
Totale 13.986